Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSC) Profit After Tax: 2018-2025

Historic Profit After Tax for Ensysce Biosciences (ENSC) over the last 7 years, with Jun 2025 value amounting to -$1.7 million.

  • Ensysce Biosciences' Profit After Tax rose 11.91% to -$1.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$6.6 million, marking a year-over-year increase of 41.65%. This contributed to the annual value of -$8.0 million for FY2024, which is 24.84% up from last year.
  • Per Ensysce Biosciences' latest filing, its Profit After Tax stood at -$1.7 million for Q2 2025, which was up 10.90% from -$1.9 million recorded in Q1 2025.
  • In the past 5 years, Ensysce Biosciences' Profit After Tax registered a high of $661,769 during Q3 2024, and its lowest value of -$17.2 million during Q3 2021.
  • For the 3-year period, Ensysce Biosciences' Profit After Tax averaged around -$2.2 million, with its median value being -$2.2 million (2023).
  • Its Profit After Tax has fluctuated over the past 5 years, first tumbled by 54,828.05% in 2021, then surged by 124.59% in 2024.
  • Ensysce Biosciences' Profit After Tax (Quarterly) stood at -$10.0 million in 2021, then soared by 45.42% to -$5.5 million in 2022, then spiked by 36.03% to -$3.5 million in 2023, then decreased by 1.71% to -$3.6 million in 2024, then rose by 11.91% to -$1.7 million in 2025.
  • Its Profit After Tax was -$1.7 million in Q2 2025, compared to -$1.9 million in Q1 2025 and -$3.6 million in Q4 2024.